Close

Meridian Bioscience (VIVO) Misses Q4 EPS by 1c

November 5, 2015 9:31 AM EST

Meridian Bioscience (NASDAQ: VIVO) reported Q4 EPS of $0.20, $0.01 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $47.1 million versus the consensus estimate of $46.6 million.

For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings